MENU
+Compare
UNCY
Stock ticker: NASDAQ
AS OF
Jul 15, 12:15 PM (EDT)
Price
$4.75
Change
-$0.13 (-2.66%)
Capitalization
62.31M

UNCY Unicycive Therapeutics Inc Forecast, Technical & Fundamental Analysis

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions... Show more

UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UNCY with price predictions
Jul 14, 2025

UNCY in upward trend: price may jump up because it broke its lower Bollinger Band on June 20, 2025

UNCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 32 cases where UNCY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UNCY's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where UNCY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where UNCY advanced for three days, in of 176 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UNCY as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UNCY turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

UNCY moved below its 50-day moving average on June 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for UNCY crossed bearishly below the 50-day moving average on June 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.528) is normal, around the industry mean (17.480). P/E Ratio (0.000) is within average values for comparable stocks, (59.327). UNCY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.459). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (39.216) is also within normal values, averaging (273.307).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UNCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

UNCY is expected to report earnings to fall 88.79% to -6 cents per share on August 18

Unicycive Therapeutics Inc UNCY Stock Earnings Reports
Q2'25
Est.
$-0.07
Q1'25
Missed
by $0.51
Q4'24
Beat
by $0.34
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.09
The last earnings report on May 14 showed earnings per share of -61 cents, missing the estimate of -10 cents. With 139.44K shares outstanding, the current market capitalization sits at 62.31M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEXNY64.300.16
+0.24%
Nexans Paris ACT
FMZNF0.19N/A
N/A
QORIA LTD.
SOSCF0.25N/A
N/A
Deoleo SA
TBBC5.48N/A
N/A
Triad Business Bank
EVKIY10.32-0.27
-2.54%
Evonik Industries AG

UNCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with CDTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
-2.59%
CDTX - UNCY
52%
Loosely correlated
+9.47%
INDP - UNCY
51%
Loosely correlated
+1.94%
ICU - UNCY
43%
Loosely correlated
-5.34%
CERO - UNCY
37%
Loosely correlated
-0.23%
UTHR - UNCY
32%
Poorly correlated
+0.73%
More